Tagged: Impact Assessments issued in 2012

Impact Assessment Fees for Pharmaceutical Services (IA 5098)

This initiative introduced in 2008, through Directions to NHS Primary Care Trusts (PCTs), a charging regime for applicants applying to provide NHS pharmaceutical services as a contribution towards the costs the NHS incurs in dealing with such applications. This IA … Read more → – Impact Assessment Fees for Pharmaceutical Services (IA 5098)

Impact Assessment for Regulations under the Health Act 2009: Control of Entry and Exit in the NHS Pharmaceutical Market (IA 5035)

To ensure a proportionate regulatory regime which encourages the supply of NHS pharmaceutical services without excessive provision in areas already adequately meeting demand, to ensure the benefits of new entry outweigh costs and to align provision more transparently with local … Read more → – Impact Assessment for Regulations under the Health Act 2009: Control of Entry and Exit in the NHS Pharmaceutical Market (IA 5035)

Impact Assessment on proposals for establishing Health Education England (IA 8040)

The impact assessment focuses on the proposal to establish Health Education England as an NDPB (currently established as a Special Health Authority). Provisions to enable this change are contained within the draft Care and Support Bill. Read Impact Assessment Health … Read more → – Impact Assessment on proposals for establishing Health Education England (IA 8040)

Impact Assessment on proposals for establishing the Health Research Authority (IA 9517)

The impact assessment focuses on the proposal to establish the Health Research Authority as an NDPB (currently established as a Special Health Authority). Provisions to enable this change are contained within the draft Care and Support Bill. Read Impact assessment … Read more → – Impact Assessment on proposals for establishing the Health Research Authority (IA 9517)

Impact Assessment on the Consolidation of UK medicines legislation (IA No. 4018)

This impact assessment was produced with regard to measuring the impact of consolidating and simplifying the fragmented legislation regulating medicines. Read Impact Assessment: Consolidation of UK medicines legislation (PDF, 119K) Read the Regulatory Policy Committee opinion (PDF, 66K)

Impact Assessment on the effect of repealing the Smoke Free Sign regulations (2007) (IA 3085)

This impact assessment was produced with regard to measuring the impact of the Government’s policy related to removing legislation which dictates location and design of no-smoking signs, whilst maintaining the requirement to have no-smoking signs. Impact assessment of the effect … Read more → – Impact Assessment on the effect of repealing the Smoke Free Sign regulations (2007) (IA 3085)

Impact Assessment on quality and safety of human organs for transplantation (IA 3018)

Impact Assessment on the Quality and Safety of Organs Intended for Transplantation Regulations 2012 which implement Directive 2010/53/EU of the European Parliament and of the Council of 7 July 2010 on standards of quality and safety of human organs intended … Read more → – Impact Assessment on quality and safety of human organs for transplantation (IA 3018)

Impact Assessment for the prohibition on the sale of tobacco from vending machines (IA 3062)

This impact assessment was produced with regard to measuring the impact of the Government’s policy related to banning the sale of cigarettes from vending machines. The main purpose of the ban being to limit the number of people under the … Read more → – Impact Assessment for the prohibition on the sale of tobacco from vending machines (IA 3062)

A new system for Workforce planning education and training (IA 8008)

This Impact Assessment has been carried out to test the impact of the Government’s policy for a new system for planning and developing the healthcare workforce as set out in Liberating the NHS: Developing the Healthcare Workforce – From Design … Read more → – A new system for Workforce planning education and training (IA 8008)

Establishment of the NHS Trust Development Authority (IA 2037)

The Government set out a clear vision for a modernised NHS with an all Foundation Trust (FT) provider landscape. NHS trusts require support to achieve FT status, including an effective appointments process to ensure capable boards and robust governance. Trusts … Read more → – Establishment of the NHS Trust Development Authority (IA 2037)